While on Venetoclax I developed frozen shoulder and other muscle and joint pain. Additionally I have plaque build up in my coronary and carotid arteries. Would Crestor or Pravocol plus Zetia be most suitable considering my muscle condition?
Thanks
Written by
Golflover1954
To view profiles and participate in discussions please or .
We are prohibited from giving medical advice, but can relate what others have done and provide scientific references for you to use or share with your medical team.
>
You can find past postings in the box on this page labeled: "Related Posts
*Muscle and joint pain.
*Joint and muscle pain
*Joint/Muscle pain
*Calquence and Muscle/Joint Pain
*Foot and muscle and joint pain"
>
This list of 240 past postings includes a few that mention venetoclax / Venclexta
Cardiovascular disease is one of the leading causes of death around the world with various efforts being made to reduce risk in patients through preventive measures. One major method for prevention has been managing cholesterol, particularly low-density lipoprotein to decrease atherosclerotic plaque burden, potentially decreasing future cardiac complications. Statins have been the gold standard therapy for hypercholesterolemia treatment due to their ease of dosing, limited drug interactions, and favorable safety profile. Unfortunately, statin therapy alone is not always effective enough to adequately control a patient’s elevated lipid levels and combination therapy may be warranted. Ezetimibe is commonly added to regimens to help augment cholesterol lowering by inhibiting the absorption of cholesterol. The recent approval of a combination tablet of high-intensity rosuvastatin and ezetimibe has introduced a potentially more beneficial option for cholesterol management in addition to the only available combination of moderate intensity simvastatin and ezetimibe. We aimed to identify potential beneficial effects of ezetimibe by comparing its use in combination with high-intensity rosuvastatin compared to a statin therapy alone or in combination with moderate intensity simvastatin through a literature review. The current evidence indicated that combination therapy outperformed statin monotherapy in reduction of low-density lipoprotein cholesterol and patients were more likely to achieve their target low-density lipoprotein cholesterol goal level. This suggests rosuvastatin/ezetimibe combination holds a potential place in therapy for patients requiring a more aggressive reduction in cholesterol to help prevent atherosclerotic disease.
Your medical team will need to check for drug / drug interactions as Grapefruit juice (CYP3A inhibition) is mentioned for some statins) sciencedirect.com/topics/me...
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.